Market Exclusive

Analyst Activity – BMO Capital Markets Reiterates Buy on AstraZeneca (NYSE:AZN)

Analyst Ratings For AstraZeneca (NYSE:AZN)

Today, BMO Capital Markets reiterated its Buy rating on AstraZeneca (NYSE:AZN) with a price target of $38.00.

Some recent analyst ratings include

Dividend information for AstraZeneca (NYSE:AZN)

AstraZeneca (NYSE:AZN) pays an annual dividend of $1.37 with a yield of 3.75% and an average dividend growth of -21.20% based on a 3 Year Average..

Dividend History for AstraZeneca (NYSE:AZN)


Recent Trading Activity for AstraZeneca (NYSE:AZN)
Shares of AstraZeneca closed the previous trading session at with 36.66999816894531 shares trading hands.

Exit mobile version